Integris-Allura IGTS Fixed Systems — FDA record Z-0227-2024

Reported ongoing

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Oct 4, 2023. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
Integris-Allura IGTS Fixed Systems
Reason
Philips has become aware of an issue with the Philips Integris-Allura, Allura Xper and Azurion systems that have been delivered to Puerto Rico without a warning label and the Source-to-Skin Distance Spacer (Tube-spacer) is missing.
Classification
Class II
Recalling firm
Philips North America
Quantity
Not supplied
Agency-reported status
Ongoing
Source record identifier
Z-0227-2024

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityINTEGRIS Allura 15-12 (mono) 68

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

United States Territories of Puerto Rico, Guam, and Virgin Islands

No US distribution state could be established from this record. Check the official notice.

Dates in the source

Report date
Nov 15, 2023
Recall initiation date
Oct 4, 2023
Center classification date
Nov 9, 2023

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records